57 results
DEF 14A
STRO
Sutro Biopharma Inc
26 Apr 19
Definitive proxy
12:00am
and co-founded the Healthcare Group in the Corporate Finance Department of Morgan Stanley. Dr. Freund currently serves on the boards of directors … of Cougar Biotechnology, Inc., Senior Director and Interim Head of Oncology/Hematology in the Department of Medical Research and Clinical Development
8-K
EX-99.2
dqex cnv492m86
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
S-3
EX-1.2
5jjkhlk
4 Oct 19
Shelf registration
4:06pm
8-K
EX-99.2
hh52b8 4c
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-1.1
6x2sjkz d3o3
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-1.1
hf2mwni
12 May 20
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-1.1
y30qycmg
9 Dec 20
Entry into a Material Definitive Agreement
4:38pm
S-3ASR
EX-1.2
igwoqa4rbceuhiy
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-1.1
x4woe7n 1ksygf2
9 Feb 24
Other Events
4:27pm
PRE 14A
mam5co5
14 Apr 23
Preliminary proxy
4:05pm